Chitosan-based Hemostasis Management Products Market to Double to $3.20B by 2033 - Strategic Revenue Insights (SRI)
Market valued at $1.45B in 2024 grows at 10.4% CAGR driven by biocompatible hemostatic solutions in surgical and trauma care settings. LONDON, UNITED KINGDOM, UNITED KINGDOM, February 4, 2026 /EINPresswire.com/ -- London, UK | February 2026 - …